January/February #151 : Expert Opinion

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Out On A Limb

Your Money or Your Life




The Sinus Monologues

Expert Opinion

Earlier HIV Meds?

HIV Treatment Guidelines Revised Again

Tea Time

Check My Meds

HIV-Med Pipeline Update

Complaint Department

Med Alert

Share the Wealth

Decreased Counts

Energy Savers

Sexual Healing

Make Those Doc Visits Count




Seeking Sisterhood

Forgotten No More

Is AIDS a Riot?

This Boy’s Life

Resistance Is Futile




Editor's Letter - Jan/Feb 2009

Letters - Jan/Feb 2009

Bear With Him

NAPWA/TAEP HIV/AIDS POLICY REPORT - Jan/Feb 2009



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

January / February 2009


Expert Opinion

A top AIDS doc weighs in on tenofovir’s impact on your kidneys.

The HIV drug tenofovir (in Viread, Atripla and Truvada) can affect kidney function in people who’ve taken HIV meds before and have underlying kidney problems.

But what about people on their first HIV combo? Researchers at Johns Hopkins University School of Medicine in Baltimore recently reviewed three years of tenofovir trials conducted by the drug’s manufacturer, Gilead Sciences.

The review found tenofovir “very safe in [treatment naive] patients,” says lead author Joel Gallant, MD, professor of medicine at Hopkins. “Kidney toxicity is unlikely in people with normal kidney function taking tenofovir in a first regimen,” Dr. Gallant says. “[But] kidney function should be monitored no matter what drugs you’re taking.” Temporary conditions affecting the kidney, such as an acute illness causing dehydration, or high doses of ibuprofen or other drugs, can increase tenofovir kidney toxicity risk.

“While I avoid tenofovir in patients with impaired kidney function, I feel comfortable using it in people with normal function [even if they] have a family history [of the disease] or other risk factors such as diabetes or high blood pressure,” Gallant says. “I can monitor their kidney function and change drugs if necessary.”

Gallant is the author of 100 Questions and Answers About HIV and AIDS (Jones and Bartlett, $20).

Search: kidneys, tenofovir, Viread, Atripla, Truvada


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adoniz89
    san dimas
    California


    usuallyhappy
    Palm Springs
    California


    usuallyhappy
    Palm Springs
    California


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been tested for hepatitis C?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.